Close Menu

NEW YORK – Enzo Biochem said today that it has received New York State Department of Health approval for use of its AmpiProbe Neisseria gonorrhoeae and Chlamydia trachomatis (CT/NG) nucleic acid amplification tests with oral (pharyngeal) and rectal specimens.

The approval enables Enzo to offer the test to residents of New York state, and adds to the company's menu of molecular diagnostic tests for sexually transmitted infections (STIs).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.